Combination compositions containing benazepril or...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/55 (2006.01) A61K 31/41 (2006.01) A61K 38/55 (2006.01)

Patent

CA 2214143

The invention relates to pharmaceutical combination compositions for the treatment of hypertension, congestive heart failure and renal failure, comprising (1) the ACE-inhibitor benazepril of formula (I) or benazeprilat of formula (II) or a pharmaceutically acceptable salt thereof, and (2) the AT1- antagonist valsartan of formula (III) or a pharmaceutically acceptable salt thereof, as weel as to methods for the treatment of hypertension, congestive heart failure and renal failure.

L'invention se rapporte à des compositions de combinaison pharmaceutique pour le traitement de l'hypertension, l'insuffisante cardiaque globale et l'insuffisance rénale, comportant (1) le bénazéprile inhibiteur de ACE de formule (I) ou le bénazéprilat de formule (II) ou un de leurs sels pharmaceutiquement acceptables, et la valsartane antagoniste AT¿1? de formule (III) ou un de leurs sels pharmaceutiquement acceptables, ainsi que les méthodes de traitement de l'hypertension, de l'insuffisance cardiaque globale et de l'insuffisance rénale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination compositions containing benazepril or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination compositions containing benazepril or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination compositions containing benazepril or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1878404

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.